> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Devices for Monitoring Warfarin Therapy
- URL: https://www.fdaweb.com/workshop-on-devices-for-monitoring-warfarin-therapy/
- Published: 2016-02-17T12:00:00.000Z
- Updated: 2026-09-15T02:36:41.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134799

*Federal Register* Notice: FDA will hold a public workshop 3/18 entitled “Point of Care Prothrombin Time/International Normalized Ratio Devices for Monitoring Warfarin Therapy.” Its purpose is to discuss approaches to the analytical and clinical validation of point of care (POC) Prothrombin Time/International Normalized Ratio (PT/INR) in vitro diagnostic devices for improved clinical management of warfarin therapy. Also, the workshop will describe FDA’s process for facilitating the development of safe and effective POC and patient self-testing PT/INR devices. The workshop had been scheduled for 1/25 and was postponed due to unanticipated weather conditions. It will be held from 8 a.m. to 5 p.m. at FDA’s White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, Rm. 1503 (the Great Room), Silver Spring, MD. Contact **Rachel Goehe**, 240-402-6565, email: Rachel.Goehe@fda.hhs.gov. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-02-17/pdf/2016-03153.pdf?ref=fdaweb.com)